Drug Shortage Report for DILAUDID
Report ID | 176095 |
Drug Identification Number | 00125083 |
Brand name | DILAUDID |
Common or Proper name | Hydromorph Contin |
Company Name | PURDUE PHARMA |
Market Status | MARKETED |
Active Ingredient(s) | HYDROMORPHONE HYDROCHLORIDE |
Strength(s) | 2MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N02AA |
ATC description | OPIOIDS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-11-24 |
Actual start date | 2022-11-24 |
Estimated end date | 2023-01-13 |
Actual end date | 2023-01-12 |
Shortage status | Resolved |
Updated date | 2023-01-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2023-01-13 | English | Compare |
v16 | 2023-01-12 | French | Compare |
v15 | 2023-01-12 | English | Compare |
v14 | 2023-01-09 | French | Compare |
v13 | 2023-01-09 | English | Compare |
v12 | 2022-12-21 | French | Compare |
v11 | 2022-12-21 | English | Compare |
v10 | 2022-12-15 | French | Compare |
v9 | 2022-12-15 | English | Compare |
v8 | 2022-12-12 | French | Compare |
v7 | 2022-12-12 | English | Compare |
v6 | 2022-12-09 | French | Compare |
v5 | 2022-12-09 | English | Compare |
v4 | 2022-12-02 | French | Compare |
v3 | 2022-12-02 | English | Compare |
v2 | 2022-11-28 | French | Compare |
v1 | 2022-11-28 | English | Compare |
Showing 1 to 17 of 17